Pharmaceutical giant Eli Lilly said Wednesday that medical testing showed that its trial drug for treatment of mild dementia from AlzheimerâÂ?Â?s disease did not slow memory loss in patients.
Key Alzheimer's Drug Fails Memory Test, Shares Plunge
Comment
Show comments
Hide Comments
